New Delhi [India], November 13 (ANI): India's cumulative COVID-19 vaccination coverage has crossed 111.95 crore doses, informed the Union Ministry of Health and Family Welfare on Saturday.
New Delhi [India], November 2 (ANI): Over 106.85 crore COVID-19 vaccine doses have been administered so far in the country, the Ministry of Health and Family Welfare said on Tuesday.
Rome [Italy], October 30 (ANI): Prime Minister Narendra Modi conveyed to leaders of G20 nations that India is ready to produce five billion COVID-19 vaccines doses by the end of 2022, Foreign Secretary Harsh Vardhan Shringla said on Saturday.
New Delhi [India], October 27 (ANI): With the administration of 55,89,124 vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 103.53 crore, informed the Ministry of Health and Family Welfare on Wednesday.
New Delhi [India], October 17 (ANI): India's cumulative COVID-19 vaccination coverage has reached the milestone of 97.65 crore doses, as per the Union Ministry of Health and Family Welfare.
New Delhi [India], October 14 (ANI): More than 27 lakhs COVID-19 vaccine doses have been administered till 7 PM on Thursday, said the Union Ministry of Health and Family Welfare.
New Delhi [India], September 30 (ANI): India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin in the month of October, said government sources.
New Delhi [India], August 25 (ANI): Union Health Minister Mansukh Mandaviya on Wednesday informed that all states will be provided with over 2 crore additional COVID-19 vaccine doses in August.
New Delhi [India], July 20 (ANI): The Ministry of Health and Family Welfare on Tuesday said more than 2.11 crore unutilised COVID-19 vaccines doses are still available with the States, UTs and private hospitals to be administered.
Paris [France), July 19 (ANI): France on Monday included Covishield produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University in the list of approved vaccines for travel to the country.
New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine cand
New Delhi [India], July 3 (ANI): As many 44,111 new COVID-19 cases and 738 deaths were reported in India in the last 24 hours, said the Ministry of Health and Family Welfare on Saturday.